Prospective Study of the Efficacy and Safety of Olopatadine 0.1% Ophthalmic Drops with Bepotastine Besilate 1.5% Ophthalmic Drops in Patients With Vernal Keratoconjunctivitis at a Tertiary Care Hospital

Authors
Category Primary study
JournalInternational journal of life sciences biotechnology and pharma research
Year 2026
This article has no abstract
Epistemonikos ID: eba820433ae870aa40876aaaa271179d049c614c
First added on: Sep 08, 2026